Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihai G Netea

Showing results (581-590 of 1,310) with videos related to

Pageof 131
Sort By:
Scientific Reports|April 5, 2020
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathologyShirin Kalyan, Mark Bazett, Ho Pan Sham, et al.
Journal for Immunotherapy of Cancer|September 18, 2020
Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristicsKatrin Rabold, Anna Aschenbrenner, Christoph Thiele, et al.
Plos Computational Biology|October 21, 2015
Integrative Genomics-Based Discovery of Novel Regulators of the Innate Antiviral ResponseRobin van der Lee, Qian Feng, Martijn A Langereis, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
An Epidemiological Survey of Sepsis in a Tertiary Academic Hospital from Southwestern RomaniaAndra Grigorescu, Florentina Dumitrescu, Stefania Dorobantu, et al.
Implementation Science Communications|March 1, 2026
Prioritized barriers to implementation of personalized immunotherapy for sepsis patientsNynke Bos, Julie E M Swillens, Lisa Vandeberg, et al.
Frontiers in Immunology|March 30, 2018
High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear CellsRob J W Arts, Po-Kai Huang, De Yang, et al.
Medical Mycology|June 6, 2012
Human genetic susceptibility to Candida infectionsTheo S Plantinga, Melissa D Johnson, William K Scott, et al.
Cytokine|April 23, 2013
Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coliKonstantinos Kopanakis, Ira-Maria Tzepi, Aikaterini Pistiki, et al.
Plos One|March 4, 2014
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosisLouis Yi Ann Chai, Bart Jan Kullberg, Arul Earnest, et al.
Mbio|July 9, 2020
Epitope Shaving Promotes Fungal Immune EvasionDelma S Childers, Gabriela Mol Avelar, Judith M Bain, et al.
Pageof 131

Showing results (581-590 of 1,310) with videos related to

Sort By:
Pageof 131
Scientific Reports|April 5, 2020
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathologyShirin Kalyan, Mark Bazett, Ho Pan Sham, et al.
Journal for Immunotherapy of Cancer|September 18, 2020
Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristicsKatrin Rabold, Anna Aschenbrenner, Christoph Thiele, et al.
Plos Computational Biology|October 21, 2015
Integrative Genomics-Based Discovery of Novel Regulators of the Innate Antiviral ResponseRobin van der Lee, Qian Feng, Martijn A Langereis, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
An Epidemiological Survey of Sepsis in a Tertiary Academic Hospital from Southwestern RomaniaAndra Grigorescu, Florentina Dumitrescu, Stefania Dorobantu, et al.
Implementation Science Communications|March 1, 2026
Prioritized barriers to implementation of personalized immunotherapy for sepsis patientsNynke Bos, Julie E M Swillens, Lisa Vandeberg, et al.
Frontiers in Immunology|March 30, 2018
High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear CellsRob J W Arts, Po-Kai Huang, De Yang, et al.
Medical Mycology|June 6, 2012
Human genetic susceptibility to Candida infectionsTheo S Plantinga, Melissa D Johnson, William K Scott, et al.
Cytokine|April 23, 2013
Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coliKonstantinos Kopanakis, Ira-Maria Tzepi, Aikaterini Pistiki, et al.
Plos One|March 4, 2014
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosisLouis Yi Ann Chai, Bart Jan Kullberg, Arul Earnest, et al.
Mbio|July 9, 2020
Epitope Shaving Promotes Fungal Immune EvasionDelma S Childers, Gabriela Mol Avelar, Judith M Bain, et al.
Pageof 131